Long-Term Care in Androgen Insensitivity Syndrome: Bone Health, Hormones and Support

The letter arrives a few weeks after a routine appointment: a bone density scan is being requested, and the clinic would like to talk about “long-term follow-up.” For a woman in her twenties with complete androgen insensitivity syndrome, who has known her diagnosis since her teens and felt perfectly well, it can land as a small shock. Nothing is wrong. Yet someone is planning decades ahead on her behalf.

That planning is the heart of AIS long-term care. Androgen insensitivity syndrome is not an illness that flares and settles; it is a lifelong difference in how the body responds to testosterone, and the consequences for bone, hormones and wellbeing unfold slowly, over years rather than weeks.

This explainer walks through what that care usually involves, what the evidence supports, where it is still uncertain, and which questions are worth bringing to the team who knows your history.

What "AIS long-term care" means here, and what it doesn't

Type the phrase into a search engine and the results scatter in odd directions: insurance designations, county aging services, staffing companies. The abbreviation is crowded. In this article AIS means one thing only: androgen insensitivity syndrome, a genetic condition in which the body’s cells cannot respond normally to androgens, the group of hormones that includes testosterone.

Long-term care, in this medical sense, has nothing to do with nursing homes or policies. It describes the structured follow-up that a person with AIS is offered across a lifetime. The National Library of Medicine’s MedlinePlus describes the condition as one that affects sexual development before birth and during puberty, which is exactly why the care does not stop once a diagnosis is made. Puberty, adult bone maintenance, gonad decisions, hormone replacement and emotional health each arrive on their own schedule.

Who provides it varies by country and by age. A child is often seen by a pediatric endocrinologist (a doctor specializing in childhood hormone conditions) alongside a geneticist, a psychologist and sometimes a surgeon. In adulthood the center of gravity shifts to an adult endocrinologist, with gynecology, bone health services and mental health professionals joining as needed. The NHS notes that support from a psychologist or counselor is considered a core part of care rather than an optional extra.

The purpose of AIS long-term care is not to fix a difference. It is to protect the things that genuinely can be harmed if neglected, chiefly bone strength and psychological wellbeing, and to make sure that irreversible decisions are taken with full information, at the right time, by the person they concern.

How androgen insensitivity syndrome actually works in the body

Every cell that responds to testosterone does so through the androgen receptor, a protein that acts like a docking station. In AIS, the gene that builds this receptor, called AR, carries a change that makes the docking station faulty or absent. Testosterone may be present in normal or even high amounts, but the message cannot get through. MedlinePlus Genetics explains that this is why people with the condition have a 46,XY chromosome pattern, which typically leads to male development, yet their bodies develop female or partly female characteristics.

The degree of receptor failure sets the type. In complete AIS (CAIS) the receptor does not work at all, so external genitalia are female at birth, and the diagnosis is often made when puberty brings breast development but no periods, or earlier when testes are found during a hernia repair. In partial AIS (PAIS) the receptor works a little, producing a wide range of appearances. In mild AIS (MAIS) the effect is subtle and may only surface as reduced fertility in an adult man.

Two facts about this mechanism shape everything that follows. First, the testes usually form and sit inside the abdomen or groin rather than descending; they produce testosterone and also estrogen, which is why a girl with CAIS develops breasts. Second, because the uterus and upper vagina do not form, periods never come and pregnancy is not possible.

MedlinePlus Genetics puts the frequency of complete AIS at 2 to 5 per 100,000 people who are genetically male, with the partial form thought to be at least as common. The condition is inherited in an X-linked pattern, meaning the gene change sits on the X chromosome and can be passed on by a mother who carries it without having any symptoms herself.

Who needs lifelong follow-up, and who is usually asked to wait

Everyone with a confirmed diagnosis of AIS is usually offered long-term follow-up, but the intensity differs. A person with complete AIS whose gonads have been removed depends entirely on prescribed hormone replacement for bone and general health, so her follow-up is regular and structured. Someone with mild AIS may need little more than an occasional review and fertility counseling.

The idea of “being asked to wait” comes up most often around surgery. Historically, children with CAIS had their testes removed early in life. Current thinking, reflected in NHS guidance, is different: because the risk of cancer in the retained gonads is considered low before puberty, many teams now recommend leaving them in place at least until puberty is complete. The gonads then produce the hormones that drive natural breast development and bone growth. Removal, if chosen at all, becomes a decision the young person can take part in.

Waiting is also the norm for any surgery on the genitals or vagina that is not medically urgent. Guidance from the NHS emphasizes that such procedures should not be rushed in infancy and that non-surgical options are explored first. The principle is simple: an irreversible operation should wait until the person it affects can weigh in.

Adults who were diagnosed and treated decades ago sometimes find they have drifted out of follow-up. Endocrinologists generally regard re-entry into care as worthwhile at any age, because bone loss after gonad removal is silent and hormone needs change over time. If your last review was years ago, asking a primary care doctor for a referral is a reasonable first step, and no one is expected to justify the gap.

Androgen insensitivity syndrome bone health: why bones need special attention

Bone is living tissue that is constantly broken down and rebuilt, and sex hormones are the site managers. In most people, estrogen slows the breakdown side of that equation while androgens support the building side. A woman with CAIS has cells that cannot hear the androgen signal, so one of the two managers is effectively absent from birth. Her bones rely heavily on estrogen, whether produced by her own gonads or supplied as replacement therapy.

This is the reason bone health sits at the center of AIS long-term care. If the gonads are removed and estrogen is not replaced, or is replaced inconsistently, bone loses density in the same way it does after an early menopause. The National Institute of Arthritis and Musculoskeletal and Skin Diseases describes low estrogen as one of the strongest drivers of osteoporosis, a condition in which bones become porous and fracture easily.

Research in CAIS suggests something more nuanced as well: even women who take estrogen faithfully tend to have somewhat lower bone density than average, particularly in the spine. The most likely explanation is that lifelong absence of androgen action matters in its own right. The evidence base here is modest, drawn from small cohorts rather than large trials, so clinicians describe it as an increased tendency rather than a certainty.

Bone density also depends on what happened during adolescence. Peak bone mass, the strongest your skeleton will ever be, is largely laid down by the early twenties. A young person with AIS who goes through puberty late, or who has a gap in hormone exposure after gonad removal, may not reach the same peak. This is one of the strongest arguments for careful hormone planning during the teenage years rather than leaving it to sort itself out later.

Bone density testing: what a DXA scan measures and what the numbers mean

The standard tool is a DXA scan, short for dual-energy X-ray absorptiometry. Two low-dose X-ray beams pass through the hip and lower spine, and the machine calculates how much mineral the bone contains. MedlinePlus describes it as quick, painless and using far less radiation than a chest X-ray. You lie on a padded table, fully clothed, for a few minutes.

The report gives two figures. The T-score compares your bone density with that of a healthy young adult; the Z-score compares it with people of your own age and sex. For younger adults, endocrinologists usually pay closer attention to the Z-score, because the T-score was designed for postmenopausal women. Interpreting these numbers in AIS has a wrinkle: reference ranges are built from typical female or male populations, and a tall woman with CAIS fits neither perfectly. This is one reason results are read by a specialist who knows the context rather than judged against a generic cutoff.

When the first scan is done, and how often it is repeated, depends on your history. A common approach is a baseline scan once adult height is reached or around the time gonads are removed, with repeats spaced according to the result and any change in hormone therapy. Your team sets that interval; there is no universal schedule.

Scans are only part of the picture. Blood tests for vitamin D, calcium and hormone levels help explain a low reading, and a history of fractures from minor falls carries weight of its own. A single low score is a prompt for conversation, not a verdict, and it is often the trend across several scans that guides decisions.

AIS hormone replacement therapy: what it does and how the timeline usually runs

Hormone replacement in AIS is prescribed for two reasons: to bring about or maintain the physical changes of puberty, and to protect bone and cardiovascular health over the decades that follow. For a woman with CAIS whose gonads have been removed, estrogen is the mainstay. It replaces what the gonads were converting from testosterone, and the body’s estrogen receptors work normally, so the hormone does its job.

How it is given, in what form and in what amount, is a decision for the prescribing endocrinologist and depends on age, bone results, other health conditions and personal preference. Estrogen comes in several delivery forms, each with its own risk profile, and clinicians weigh factors such as clotting risk when choosing. None of this is settled in a magazine article; it is settled in a consultation.

Timelines are gentler than people expect. Symptoms of estrogen deficiency such as hot flashes or vaginal dryness, which can appear if therapy is interrupted, usually ease within weeks of restarting. Effects on bone are slower and measured in years; a repeat DXA scan is the only way to see them, which is why consistency matters more than any single day’s tablet or patch.

Testosterone has been studied as an alternative in some women with CAIS, on the theory that a partly functioning receptor might benefit, or that the body converts it to estrogen anyway. Evidence from these small studies has been mixed and does not show clear superiority, so most guidance treats estrogen as standard and testosterone as an area of research. Whatever is prescribed, the advice from clinicians is consistent: do not stop or alter it without speaking to the team, because bone loss from gaps in therapy is silent until a scan or a fracture reveals it.

Androgen insensitivity syndrome gonadectomy: keeping or removing the gonads

Gonadectomy means surgical removal of the gonads, in this case testes that sit inside the abdomen or groin. For decades it was routine in CAIS, often done in childhood without the child’s knowledge. The reasoning was cancer prevention: undescended testes carry an increased risk of germ cell tumors, cancers arising from the cells that would normally form sperm.

The picture has become more balanced. The NHS notes that the tumor risk is small before puberty and rises with age, which has shifted advice toward leaving the gonads in place through adolescence so that natural hormone production drives puberty and bone building. After that, the decision is genuinely open. Some women choose removal in early adulthood and start estrogen replacement. Others choose to keep their gonads, accepting an uncertain long-term risk in exchange for their own hormones and no surgery.

Neither route is risk-free, and the honest position is that the evidence on lifetime cancer risk in adult CAIS is drawn from small, older series and is still debated. If gonads are kept, most teams recommend a surveillance plan, though imaging of intra-abdominal gonads is imperfect and no monitoring method has been proven to catch every tumor early. If gonads are removed, the trade-off is lifelong dependence on prescribed hormones and the possibility of symptoms if therapy is interrupted.

In partial AIS, where gonads may be partly descended and the tumor risk is thought to be higher, teams often lean more toward removal, but again with individual discussion. The most important shift in modern practice is procedural rather than surgical: the person concerned should hear the uncertainties plainly, have time to decide, and know that choosing to wait is itself a legitimate decision.

Complete androgen insensitivity syndrome treatment compared with partial and mild forms

Because AIS is a spectrum, the long-term plan differs by type. The table summarizes what typically distinguishes them; every row is a generalization that a treating team will adapt to the individual.

Aspect	Complete AIS	Partial AIS	Mild AIS
Receptor function	Absent	Reduced	Slightly reduced
Usual presentation	Female appearance; no periods at puberty, or testes found in childhood hernia	Variable genital appearance at birth; range of pubertal changes	Male appearance; may present with infertility or breast tissue in adulthood
Hormone focus	Estrogen after gonad removal or if gonads under-produce	Depends on gender of rearing and gonad status; may involve estrogen or testosterone	Often none; sometimes evaluation of fertility
Gonad decision	Often deferred to adulthood; retention or removal both discussed	Removal more often advised because tumor risk is thought higher	Gonads usually retained
Bone monitoring	Central to follow-up	Important, tailored	Individual basis
Psychological support	Offered lifelong	Offered lifelong; gender questions may be more prominent	Offered as needed

Two threads run across all three columns. Hormone health and bone health are linked in every form, and psychological support is never an afterthought. Partial AIS deserves a special note: because the appearance at birth varies so widely, questions about gender identity, surgery timing and hormone choice are more complex, and multidisciplinary teams that include psychologists are considered the standard of care by the NHS and others. The choice of which hormone to use in PAIS follows the person’s identity and wishes as they mature, not a fixed rule.

Fertility, intimacy and vaginal health across the years

People often ask these questions quietly, or not at all, so it is worth answering them plainly. A woman with complete AIS does not have a uterus and cannot carry a pregnancy; the gonads do not produce eggs, so biological parenthood is not possible with current medicine. MedlinePlus and the NHS both state this directly. Adoption and other routes to parenthood remain fully open, and many women with AIS raise families.

In mild AIS, a man may have reduced sperm production. Fertility specialists can assess this, and in some cases assisted reproduction is an option; outcomes depend on individual findings and should be discussed with a fertility team rather than assumed.

The vagina in CAIS forms from tissue that does not depend on androgens, so it is present but is often shorter than average because the upper portion, which develops with the uterus, is absent. This may make penetrative sex uncomfortable at first. The NHS describes vaginal dilation, the gradual use of smooth graded dilators over weeks to months to lengthen and stretch the tissue, as the first approach, and notes that surgery is considered only if dilation does not achieve what the person wants. Dilation is something adults choose for themselves when it feels relevant; it is not imposed in childhood.

Estrogen also keeps vaginal tissue supple, so a lapse in hormone therapy can cause dryness, another reason consistency matters. Sensation and the capacity for pleasure are not altered by the condition itself. Where earlier surgery has left scarring or reduced sensitivity, a gynecologist or a specialist in sexual health can advise, and psychosexual counseling is a recognized part of AIS support rather than a niche referral.

Mental health, disclosure and finding your people

The medical facts of AIS are manageable. What many adults describe as hardest is the way they learned about them. A generation ago it was common for diagnoses to be withheld from the child, disclosed partially to parents, or delivered in language that framed the body as a problem to be corrected. The NHS now explicitly recommends that psychological support be offered to the child and the family from diagnosis onward, and that information be shared honestly in an age-appropriate way.

For adults, the emotional work often centers on three things: coming to terms with infertility, deciding whom to tell and when, and untangling old feelings of secrecy or shame. Counselors who understand differences of sex development are better placed to help than generalists, and a good endocrinology service will know how to reach them.

Peer support has a particular power here. Meeting another person with the same condition, often for the first time in adulthood, is described by many as the moment the diagnosis stopped feeling like a private oddity. Patient-led support groups exist in many countries, and clinicians increasingly regard connecting patients to them as part of good care. Ask your team what they know of.

Gender identity deserves a direct word. Most people with complete AIS identify as women. In partial AIS, where appearance at birth and rearing decisions vary, some people later identify differently from the gender they were assigned. None of this is a disorder to be managed; it is a reason teams now avoid irreversible surgery in infancy and keep psychological support in place as young people grow. The person’s own sense of self leads, and care follows.

Nutrition, movement and everyday habits that support AIS long-term care

Hormone therapy protects bone, but bone also responds to what you eat and how you move, and these are the parts of AIS long-term care that sit in your own hands.

Calcium and vitamin D are the raw materials. The NIH Office of Dietary Supplements sets recommended daily intakes that vary by age, and it notes that most people can meet calcium needs through food such as dairy, fortified plant milks, leafy greens and canned fish with bones. Vitamin D is harder to get from diet alone; skin makes it from sunlight, and people who live at northern latitudes, cover their skin or spend little time outdoors are often low. Whether you need a supplement, and how much, is a question for your team based on a blood test, not a guess from a label.

Movement matters in a specific way. Bone strengthens in response to load, so weight-bearing exercise such as brisk walking, jogging, dancing or stair climbing, and resistance work with weights or bands, does more for the skeleton than swimming or cycling alone. The NIAMS points out that muscle strength also protects against falls, which is where fractures actually happen. Two or three sessions a week is a common starting point; the right program depends on your fitness and any joint issues.

Smoking and heavy alcohol use both accelerate bone loss and are worth raising with your doctor if they apply. Sleep, stress and body weight play smaller but real roles. None of these habits replaces hormone therapy, and none is a test of virtue. They are the ordinary things that give prescribed treatment the best chance of working, and they happen to be good for the heart and mood as well.

What people often get wrong about AIS

“AIS means someone is really male.” Chromosomes are one input into sex development, not the whole story. A woman with CAIS has a 46,XY pattern and a female body, identity and life. Medical bodies including the NHS describe her as a woman with a genetic condition, full stop.

“The gonads must come out immediately because of cancer.” The NHS and current expert consensus regard the risk as low before puberty and now favor delaying any decision until the person can take part. Removal remains a reasonable choice for many adults; the point is that it is a choice.

“Once you are on hormones, bone is no longer a concern.” Estrogen replacement is the cornerstone of bone protection, but small studies suggest women with CAIS may still run somewhat lower bone density than average. Periodic scans remain part of care even when therapy is consistent.

“It is a rare curiosity, so few doctors know anything about it.” At 2 to 5 per 100,000, according to MedlinePlus Genetics, complete AIS is uncommon, but endocrinologists are trained in it, and specialist multidisciplinary services exist in many health systems. Feeling unknown is a real experience for many patients, and it is a reason to seek a service with the right expertise rather than a reason to avoid care.

“It runs in families, so everyone will be affected.” AIS is X-linked. A mother who carries the gene change has a chance of passing it to each child, but not a certainty, and genetic counseling can explain the pattern and the testing options for relatives.

“Surgery in infancy avoids problems later.” Adults who had early, non-urgent surgery report mixed experiences, and modern guidance leans against it. Avoiding regret is a stronger argument than avoiding a conversation.

Questions to ask your care team

Consultations are short and the subject is large, so it helps to arrive with questions written down. The following are ones that people with AIS and their families commonly find useful; pick the ones that fit your situation.

• Which type of AIS do I have, and has the genetic change in my AR gene been confirmed?
• What is the current status of my gonads, and what are the arguments for keeping them or removing them in my case?
• If I keep my gonads, what surveillance do you recommend, and how reliable is it?
• What hormone therapy am I on, why this form, and what would change if my bone results or health changed?
• When was my last bone density scan, what did the Z-score show, and when should the next one be?
• Should my vitamin D and calcium levels be checked, and do I need a supplement based on results?
• Who on the team can I speak to about sexual health, dilation or any past surgery?
• Can you refer me to a psychologist or counselor with experience in differences of sex development?
• Do you know of a peer support group I could contact?
• Should my relatives be offered genetic counseling or carrier testing?
• What symptoms should prompt me to contact you between appointments?
• If I move or change health systems, how do I make sure my follow-up continues?

A good answer to most of these is not a single sentence but a conversation, and it is fair to ask for time to think before agreeing to anything irreversible. Bringing a partner, parent or friend to appointments can help with remembering what was said. If you were diagnosed long ago and have documents you do not fully understand, asking the team to walk you through your own history is entirely reasonable.

When to call your doctor

Most of AIS long-term care is calm and scheduled. A few situations, though, should prompt a call between routine appointments rather than waiting for the next one.

Contact your team promptly if you develop a new lump or swelling in the groin or lower abdomen, persistent pelvic or abdominal pain, or unexplained abdominal bloating, particularly if your gonads have been retained. These symptoms are usually benign, but they are the ones a gonad surveillance plan is designed to catch, and they warrant assessment rather than reassurance from a search engine.

Call if you have a fracture from a fall from standing height or less, or sudden back pain that does not settle, since both can signal weakened bone. Do the same if you have run out of hormone therapy or stopped it for more than a few weeks, whether by choice or circumstance; gaps matter for bone, and your team can help you restart safely.

Symptoms that can accompany estrogen therapy and need urgent attention include a painful, swollen calf, sudden breathlessness or chest pain, severe headache with visual disturbance, or weakness on one side of the body. These may indicate a blood clot or stroke and are emergencies: seek immediate care rather than waiting for a clinic call back.

Emotional red flags count just as much. Persistent low mood, anxiety that interferes with daily life, or thoughts of self-harm deserve the same prompt response as a physical symptom. Your team can connect you with mental health support, and in a crisis local emergency services or a crisis line are the right first call.

Every decision about investigation and treatment sits with the clinicians who know your history. This guide can help you recognize what matters; they decide what to do about it.

Frequently asked questions

What does AIS stand for in this article, and in healthcare generally?

Here, AIS stands for androgen insensitivity syndrome, a genetic condition in which the body’s cells cannot respond normally to testosterone. The same three letters are used for unrelated things elsewhere, including insurance designations and some local aging services, which is why search results can be confusing. If a clinician uses the abbreviation, it is reasonable to ask which meaning they intend.

Is AIS long-term care the same as long-term care insurance?

No. Long-term care in the medical sense used here means lifelong specialist follow-up for a chronic condition, in this case androgen insensitivity syndrome. Long-term care insurance is a financial product covering nursing or home care in later life and has no connection to the condition. This article does not discuss costs or insurance; those questions belong with your health system or an independent adviser.

Does androgen insensitivity syndrome require treatment for life?

Usually some form of follow-up continues for life, though what it involves varies by type. A woman with complete AIS whose gonads have been removed needs ongoing hormone replacement and bone monitoring. Someone with mild AIS may need only occasional review. The NHS describes multidisciplinary care, including psychological support, as a continuing offer rather than a one-time intervention, with the plan adjusted as needs change.

Why does androgen insensitivity syndrome bone health need extra monitoring?

Because the body’s cells cannot use androgens, bone relies almost entirely on estrogen for protection. If the gonads are removed and estrogen is not replaced consistently, density falls as it would after early menopause. Small studies also suggest women with complete AIS may have somewhat lower bone density even on treatment, so endocrinologists include periodic DXA scans in long-term follow-up.

What is AIS hormone replacement therapy for, and does it have to be estrogen?

Hormone replacement in AIS supports pubertal development where needed and protects bone and general health after the gonads stop producing hormone or are removed. Estrogen is standard in complete AIS because estrogen receptors work normally. Testosterone has been studied in small trials with mixed results and is not established as superior. The form and amount are decided by the prescribing endocrinologist, never changed on your own.

Is androgen insensitivity syndrome gonadectomy always necessary?

Not necessarily. Removal was once routine in childhood, but the NHS now notes that cancer risk in retained gonads is small before puberty, so many teams delay the decision until the person can take part. Some adults choose removal and start estrogen; others keep their gonads with a surveillance plan. Partial AIS is often approached differently because tumor risk is thought higher. The choice is individual.

Can a woman with complete androgen insensitivity syndrome become pregnant?

No. In complete AIS the uterus does not form and the gonads do not produce eggs, so pregnancy is not possible with current medicine, as MedlinePlus and the NHS both state. Adoption and other paths to parenthood remain fully open. Coming to terms with this is a recognized focus of psychological support, and counselors with experience in differences of sex development can help.

Is complete androgen insensitivity syndrome treatment different from partial AIS?

Yes, in emphasis. Complete AIS care centers on estrogen replacement, bone monitoring and an informed gonad decision. Partial AIS involves a wider range of appearances and hormone choices, more frequent recommendation of gonad removal because of higher presumed tumor risk, and closer attention to gender identity as the young person grows. Both forms rely on multidisciplinary teams that include psychological support.

Is AIS hereditary, and should my relatives be tested?

AIS is X-linked, meaning the gene change sits on the X chromosome and can be passed on by a mother who carries it without symptoms. Some cases arise from a new mutation. MedlinePlus Genetics describes this pattern. Genetic counseling can explain the chances for each relative and the options for carrier testing, and your endocrinologist can arrange a referral.

What symptoms in AIS should prompt an urgent call rather than waiting for a routine review?

A new lump or swelling in the groin or abdomen, persistent pelvic pain, a fracture from a minor fall, or a gap of several weeks in hormone therapy all warrant contacting your team promptly. A swollen painful calf, sudden breathlessness, chest pain or severe headache with visual changes can signal a clot and need emergency care. Persistent low mood or thoughts of self-harm deserve the same urgency.

References

• MedlinePlus Genetics: Androgen insensitivity syndrome
• NHS: Androgen insensitivity syndrome
• MedlinePlus: Bone Density
• NIH NIAMS: Osteoporosis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.